spacer
home > pmps > summer 2008 > instant access
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Instant Access

Few would argue with the need for pharmaceutical businesses to follow safe and proven quality assurance procedures. To this end, companies have been operating traceability systems and keeping records founded on good manufacturing practice (GMP) and good distribution practice (GDP) for a number of years. More recently, as automated monitoring and recording systems have become more commonplace, 21 CFR Part 11 has been introduced and provides appropriate guidelines for the application of electronic record keeping and signatures. Effectively, 21 CFR Part 11 defines the criteria under which electronic records and electronic signatures are considered to be trustworthy and reliable. MHRA guidelines share many of the safeguards.

Temperature and humidity have always been important factors in the pharmaceutical industry, but never more so than now. Levels in key areas, such as laboratories, cold stores, chill rooms, incubators, test chambers, production processes and storage areas need to be regularly monitored and procedures put in place to establish corrective actions if they move outside pre-set limits. Documents, together with complete and comprehensive records, need to be kept and electronic systems need to comply with necessary guidelines.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Andy Wallace was educated at Staffordshire University and has a degree in Electrical and Electronic Engineering. He worked for British Aerospace before joining Comark and has over 15 years’ experience working in the test and measurement industry. He has progressed within Comark from Service Engineer through to Technical Services, before being appointed Product Manager and taking responsibility for the complete product range eight years ago. His current role involves identifying market requirements and liaising with development engineers to provide cutting-edge technical solutions for temperature and humidity monitoring.
spacer
Andy Wallace
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Ashfield Launches Cell & Gene Therapy Commercialization Network, EmerGENE

14th July 2021 Ashfield, part of UDG Healthcare plc, has announced the launch of EmerGENE, a global end-to-end cell and gene therapy network approach which promises to support small and midsize biotechs with the commercialization of their discoveries.
More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement